News
Clinical Trial News Press Release
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis
Event
4Moving Biotech at ATio 2025
Event
4Moving Biotech at EULAR CONGRESS 2025
Event
GLP-1/GLP-1R AXIS TO TREAT OSTEOARTHRITIS A NEW OPPORTUNITY
Event
Spotlight on Our OARSI Congress Poster
Event
4Moving Biotech at OARSI 2025
End of content